Non Hodgkin Lymphoma Clinical Trial

Managing Pain and Symptom Burden Caused by Chemotherapy in People With Myeloma or Lymphoma

Summary

The purpose of this study is to find out whether acupuncture treatments can reduce the need for opioid medication when managing pain caused by chemotherapy. The study will compare the effects of adding acupuncture to usual pain management with those of usual pain management alone, in reducing opioid use by relieving pain. Researchers also want to find out more about the effects of acupuncture treatments on other symptoms caused by cancer treatments and quality of life.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

age 18 or older
pathological diagnosis of MM, HD or NHL
scheduled for high dose chemotherapy for auto-HSCT in the following month (30 days)
not taking opioids regularly in the week prior to consent (one-time dosing of opioids for a painful procedure is allowed)

Exclusion Criteria:

absolute neutrophil count (ANC) of <500>2.0
acupuncture within two weeks prior to HiChemo (to avoid residual effects of acupuncture)
unable to provide informed consent

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 3

Estimated Enrollment:

300

Study ID:

NCT04459416

Recruitment Status:

Recruiting

Sponsor:

Memorial Sloan Kettering Cancer Center

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 2 Locations for this study

See Locations Near You

Memorial Sloan Kettering Cancer Center
New York New York, 10065, United States More Info
Gary Deng, MD, PhD
Contact
646-888-0815
Sergio Giralt, MD
Contact
212-639-3859
Gary Deng, MD, PhD
Principal Investigator
Fred Hutchinson Cancer Research Center
Seattle Washington, 98109, United States More Info
Heather Greenlee, MD
Contact
206-667-4502
Seattle Cancel Care Alliance (Data Collection Only)
Seattle Washington, 98109, United States More Info
Heather Greenlee, MD
Contact
206-606-7222

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Phase:

Phase 3

Estimated Enrollment:

300

Study ID:

NCT04459416

Recruitment Status:

Recruiting

Sponsor:


Memorial Sloan Kettering Cancer Center

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.